Navigating the therapeutic itinerary: Access to healthcare services and medications for endometriosis

Carolina de Souza Peruzzo, Gustavo Magno Baldin Tiguman, Patrícia Melo Aguiar
In: Journal of Endometriosis and Pelvic Pain Disorders · 2025 · vol. 17(4) , pp. 169–177 · doi:10.1177/22840265251340363 · W4410452878
article OA: closed CC0
View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This study investigated healthcare and medication access for endometriosis patients in Brazil, finding diagnostic delays and barriers to specialists, with direct purchase of medications being common and associated with socioeconomic factors.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Background: Endometriosis is a chronic condition causing pain and fertility issues. This study aimed to evaluate access to health services and medication among patients with endometriosis in Brazil. Methods: A cross-sectional study was conducted from March to June 2022, collecting data on clinical diagnosis, access to health services, medications used, and potential barriers to access. Exploratory descriptive analysis was conducted and associated factors were identified through multivariate logistic regression. Results: Eight hundred eighty-five valid responses were obtained. 29.6% of patients took 1–5 years for diagnosis, with private services being the most used for diagnosis (57.6%) and follow-up (52.8%). 90.1% had difficulty finding specialists. Main medication access was through direct purchase (91.2%). People with health insurance were more likely to have full access to medicines than people without (OR = 1.94; 95%CI 1.36–2.77). Older people were less likely to have full access (45–59 years: OR = 0.39 (95%CI 0.19–0.81)) than young adults aged 18–24. Black people were less likely to have full access than white people (OR = 0.61 (95%CI 0.37–0.99)). People with higher incomes were more likely to have full access than poorer people (2–4 minimum wages: OR = 2.10 (95%CI 1.41–3.12)). The most used drugs were sex hormones and modulators of the genital system (90.5%), especially hormonal contraceptives for systemic use. Off-label use of antidepressants and antiepileptics was commonly observed for the treatment of endometriosis. Conclusion: The study revealed that patients with endometriosis face significant challenges in accessing treatment in Brazil, particularly due to the limited therapeutic options and off-label use of medications.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (33)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK